Given that CD36, a pathogenic factor of NAFLD, usually contributes to fatty acid uptake and triglyceride accumulation,[22, 23] the probable relationship between CD36 and Rubicon in the NAFLD process was initially assessed. Here, CD36 is linked to metabolic dysfunction-associated steatotic liver disease.